Hot flushes: mostly sex neutral?

The Lancet Oncology

Volumn 11, Issue 2, 2010, Pages 107-108

  Loprinzi, Charles L ^a   Wolf, Sherry L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; CYPROTERONE ACETATE; ESTROGEN; GABAPENTIN; MEDROXYPROGESTERONE ACETATE; PAROXETINE; PLACEBO; PROGESTERONE DERIVATIVE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; VENLAFAXINE;

ANDROGEN DEPRIVATION THERAPY; BREAST CANCER; CLINICAL TRIAL; DRUG EFFICACY; ESTROGEN SYNTHESIS; HOT FLUSH; HUMAN; LETTER; MENOPAUSE; PRIORITY JOURNAL; PROSTATE CANCER; SEX DIFFERENCE;

FEMALE; HOT FLASHES; HUMANS; MALE; SEX FACTORS;

EID: 75249086679     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70349-3     Document Type: Letter

References (14)

1. Barlow D.H. Venlafaxine for hot flushes. Lancet 356 (2000) 2025-2026
2. Loprinzi C.L., Kugler J.W., Sloan J.A., et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 356 (2000) 2059-2063
3. Loprinzi C.L., Sloan J., Stearns V., et al. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol 27 (2009) 2831-2837
4. Bardia A., Novotny P., Sloan J., Barton D., and Loprinzi C. Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis. Menopause 16 (2009) 477-483
5. Loprinzi C.L., Michalak J.C., Quella S.K., et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med 331 (1994) 347-352
6. Atala A., Amin M., and Harty J.I. Diethylstilbestrol in treatment of postorchiectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone, and testosterone. Urology 39 (1992) 108-110
7. Miller J.I., and Ahmann F.R. Treatment of castration-induced menopausal symptoms with low dose diethylstilbestrol in men with advanced prostate cancer. Urology 40 (1992) 499-502
8. Loprinzi C.L., Dueck A.C., Khoyratty B.S., et al. A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Ann Oncol 20 (2009) 542-549
9. Loprinzi C.L., Pisansky T.M., Fonseca R., et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol 16 (1998) 2377-2381
10. Quella S.K., Loprinzi C.L., Sloan J., et al. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol 162 (1999) 98-102
11. Roth A.J., and Scher H.I. Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer. Psychooncology 7 (1998) 129-132
12. Irani J., Salomon L., Oba R., Bouchard P., and Mottet N. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. Lancet Oncol (2009) 10.1016/S1470-2045(09)70338-9 published online Dec 7, 2009.
13. Loprinzi C.L., Levitt R., Barton D., et al. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. J Clin Oncol 24 (2006) 1409-1414
14. Loprinzi C.L., Goldberg R.M., O'Fallon J.R., et al. Transdermal clonidine for ameliorating post-orchiectomy hot flashes. J Urol 151 (1994) 634-636